Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Open communication with your healthcare provider helps mitigate possible risks
IGF-1 LR3 is better able to stimulate the type 1 IGF receptor and thus induce a higher level of intracellular signaling, cell proliferation and inhibition of apoptosis
Legitimate pharmaceutical manufacturing requires extensive regulatory licensing, inspection records, and public documentation
TRIUMPH-1 (80 Weeks) The pivotal TRIUMPH-1 obesity trial (2,339 adults, no diabetes), presented at ADA 2026, extended the treatment window to 80 weeks and produced the largest pivotal weight-loss readout to date: Among the 12 mg group, 45.3% lost at least 30% of their body weight and 65.3% ended the trial with a BMI below 30
US$ 27.07
US$ 21.66
US$ 26.85
US$ 27.66
US$ 27.51
US$ 25.58
US$ 21.25
